For International Polar Bear Day, we're sharing the heartwarming story of a plucky and beloved bear who benefited from a company donation of medical supplies for a challenging surgery.
Article
By Linda Lombardi
Nora the polar bear is just 3 years old, but she has already faced a host of challenges.
Philemon Padonou overcame great obstacles to become a lead software developer—a job that inspired him to start a nonprofit called CodeToHope. For National Engineers Week, we highlight his amazing story.
It's one hard-working organ, pumping 1.5 gallons of blood every minute and beating around 100,000 times a day. In honor of American Heart Month, we sat down with a ticker expert to learn about things most people may not know about their hearts—and advances that could change cardiac care.
IBM and Johnson & Johnson Team up in Santiago to Strengthen Community Resilience
Article
The term “natural disaster” is a misnomer. Natural ecosystems often require disturbances such as fires and floods to remain healthy. They have an inherent resilience to the occasional battering. Crises created by destructive natural events might be more aptly referred to as “social disasters,” because of the toll of life and economic damage left in their wake. Framing such events as social disasters places them in a different light, shifting the burden on all sectors of society to proactively manage the threat.
The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.
Article
The results are in, and Johnson & Johnson has been named to Fortune’s list of the World’s Most Admired Companies for the 17th year, ranking in the top 20. Johnson & Johnson also placed #1 in the Pharmaceutical category worldwide for the sixth consecutive year, making it the highest-ranked healthcare company to appear on the top companies list in 2019.
Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
Article
Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who's hard at work on the holy grail of HIV research: a preventive treatment.
Article
By Sheila Weller
In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.
The company has secured a top ranking on the biannual report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the sixth consecutive time.
Article
One billion. That's how many lives Johnson & Johnson is committed to impacting through its Health for Humanity 2020 Goals, which include a pledge to deliver innovative healthcare access to some of the world's most underserved communities and cutting-edge training programs for frontline healthcare workers.
It's one of the company's largest commitments to date, and it aims to help support the crucial work being done by frontline health workers to help more children grow up healthy.
Article
If there's one universal truth about kids, it may be this: They want to grow up as quickly as possible. And for over 100 years, Johnson & Johnson has been working to help them grow up as healthy as possible, too.
